CreativeOne Wealth LLC Purchases New Shares in iShares Biotechnology ETF (NASDAQ:IBB)

Posted by Brian Wu on Dec 2nd, 2024

CreativeOne Wealth LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the third quarter, Holdings Channel reports. The institutional investor purchased 2,696 shares of the financial services provider’s stock, valued at approximately $392,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $29,000. Highline Wealth Partners LLC acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $30,000. Bbjs Financial Advisors LLC acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at $31,000. Ashton Thomas Securities LLC acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $36,000. Finally, Voisard Asset Management Group Inc. acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $59,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $141.55 on Monday. The company’s fifty day moving average price is $142.71 and its 200 day moving average price is $142.06. iShares Biotechnology ETF has a 1 year low of $119.95 and a 1 year high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.